Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

MNKD $0.55 0.0700 +14.58%
CASC $5.50 0.5300 +10.66%
BLCM $18.72 1.7400 +10.25%
SYRS $15.47 1.3900 +9.87%
CTIC $0.49 0.0430 +9.73%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TRIL $6.70 -0.5000 -6.94%
MRTX $5.05 -0.2000 -3.81%
BPMC $27.01 -0.9900 -3.54%
RXDX $5.95 -0.2000 -3.25%
LBIO $6.00 -0.2000 -3.23%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next > | Last >>

Whites Have Longest Survival in Cutaneous Melanoma

(Physician’s Briefing/HealthDay News) Oct 28, 2016 - For patients with cutaneous melanoma, whites have the longest survival time, according to a study published in the November issue of the Journal of the American Academy of Dermatology.
read article 



Genetic Variant Reduces Risk for HPV-Related Oropharyngeal Cancer

(Medscape Medical News) Oct 28, 2016 - The development of head and neck cancers may be influenced by an individual's human papillomavirus (HPV) infection status, reveals a large-scale study that found several novel genetic loci associated with oral cavity and pharyngeal cancers.
read article (free registration required) 



Breast Reconstruction Worthwhile for Older Women: Study

(U.S. News & World Report/HealthDay News) Oct 28, 2016 - Older women who have had a breast removed due to cancer benefit as much as younger women from breast reconstruction, a new study shows.
read article 



Women Unclear About Breast Density, Breast Cancer Risks

(Reuters Health) Oct 28, 2016 - Women are becoming more aware of the term “breast density,” but they aren’t as familiar with its relation to breast cancer risk or mammograms, according to a small U.S. study.
read article 



October 28: CVS Indicates Reversal of Decision to Block Oncology Clinics Dispensing Patients’ Drugs

(COA) Oct 28, 2016 - The Community Oncology Alliance (COA) has recently learned that CVS Health is indicating it will not proceed with restricting cancer patients from receiving their medications from oncology practices that dispense medications.
read article 



ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib

(Yahoo! Finance) Oct 31, 2016 - Brigatinib granted Priority Review, with a PDUFA date of April 29, 2017.
read article 



European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

(Merck) Oct 31, 2016 - If approved, avelumab, an investigational anti-PD-L1 IgG1, could be the first treatment indicated for patients with metastatic Merkel cell carcinoma; the Marketing Authorization Application is based on Phase II data from the JAVELIN Merkel 200 study demonstrating meaningful tumor responses in patients with metastatic disease that progressed after prior chemotherapy; JAVELIN Merkel 200 is the largest reported anti-PD-L1/PD-1 antibody study in this patient population.
read corporate press release 



Saving Ava: When A Cancer Drug Shortage Imperiled A Toddler, Her Mom Got To Work

(STAT) Oct 31, 2016 - Though it was tough to listen to her baby wail, Luciano knew this medicine was essential for wiping out any last leukemia cells lurking in Ava’s body. The drug, called Erwinaze, is one of a small number of critical medications in short supply right now in the United States.
read article 



Anal Cancer Rising Worldwide

(American Cancer Society) Oct 28, 2016 – A new American Cancer Society study finds that incidence of anal cancer has been increasing in women or in both men and women in 13 of 18 countries studied, particularly in the Americas, Northern and Western Europe, and Australia.
read press release 



Celgene May Be Ready to Lap Bristol

(Bloomberg/Gadfly blog) Oct 28, 2016 - The distinction between big biotech and big pharma has grown increasingly moot as several biotechs have gotten larger than their much older peers.
read article 



Opinion: The U.S. Is Standing in the Way of Cheaper Drugs for the Poor

(New York Times) Oct 27, 2016 - Every few months, a drug company gets caught cranking up prices.
read article 



Patient Values May Not Always Align With Choices for End of Life Care

(Reuters) Oct 27, 2016 - Patients and families state that they value comfort, having time with family and death not being prolonged, but these values often don’t align with the treatment they expect at the end of life, according to a new Canadian study.
read article 



Study Finds Significant Differences In Plans Sold On Or Off The Exchanges

(Kaiser Health News) Oct 28, 2016 - Three years after opening their online doors, the health insurance marketplaces remain under intense scrutiny, but individual health plans that are not sold through these exchanges have largely escaped attention. New research sheds some light on what these plans are like and how they fit into the overall individual market.
read article 



How Are Hospital-Based ACOs Addressing Community Health?

(Health Affairs Blog) Oct 27, 2016 - As Risa Lavizzo-Mourey, president and CEO of the Robert Wood Johnson Foundation (RWJF), noted earlier this year, Accountable Care Organizations (ACOs) are no longer the “mythical unicorn creatures” they once were. In just six short years following the enactment of the Affordable Care Act (ACA), ACOs have moved from a small market experiment to now being responsible for the health care—and the health care costs—of nearly 30 million Americans.
read article 



Adaptive Biotechnologies Announces the Inclusion of NGS-Based MRD Assessment in the NCCN Clinical Practice Guidelines for Multiple Myeloma

(Yahoo! Finance) Oct 27, 2016 - Adaptive Biotechnologies, the leader in combining next-generation sequencing (NGS) and expert bioinformatics to profile T- and B-cell receptors of the adaptive immune system, announces that the National Comprehensive Cancer Network (NCCN) revised their clinical practice guidelines recommending the use of highly sensitive diagnostic tools, including NGS, to assess the presence of measurable residual disease (MRD) in Multiple Myeloma.
read article 



Could Minority-Serving Hospitals Be Unfairly Penalized By CMS for Readmissions?

(Georgetown University Medical Center) Oct 28, 2016 - A new probe into why colorectal surgery patients end up back in the hospital after surgery suggests that it has less to do with the hospital or treatment received but rather more determined by patient factors such as race, income, and insurance status.
read press release 



TESARO Announces Acceptance for Review of Niraparib Marketing Authorization Application by EMA

(TESARO) Oct 27, 2016 - TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that the Marketing Authorisation Application (MAA) for niraparib has been submitted to and accepted for review by the European Medicines Agency (EMA) for the maintenance treatment of patients with platinum-sensitive, recurrent ovarian cancer who are in response to platinum-based chemotherapy. With this acceptance, the review of the niraparib marketing authorisation application in the Centralised Procedure will now begin.
read corporate press release 



Pitt, Partners Create Open Source Software for Cancer Genome Data

(Pittsburgh Business Times) Oct 27, 2016 - Researchers at the University of Pittsburgh, UPMC and the Pittsburgh Supercomputing Center have created software to help investigators more easily navigate genomic cancer data.
read article 



How Will Personalized Medicine Shift From Great Concept To Reality?

(Forbes) Oct 25, 2016 - In a recent Oxford Economics study, “Healthcare Gets Personal,” 120 healthcare professionals were asked to respond to questions regarding their organizations’ use of personalized medicine.
read article 



Astellas to Acquire Ganymed Pharmaceuticals

(Astellas) Oct 28, 2016 - Astellas Pharma Inc. and Ganymed Pharmaceuticals AG, a biopharmaceutical company located in Mainz, Germany which focuses on the development of antibodies against cancer, announced today that Astellas and Ganymed's shareholders have entered into an agreement for Astellas to acquire Ganymed. The transaction would enable Astellas to continue to build upon its leading oncology franchise as a platform for sustainable growth.
read corporate press release 



Test for Postoperative Radiation Response in Prostate Cancer

(Medscape Medical News) Oct 27, 2016 - For the first time in prostate cancer research, a 24-gene molecular signature can predict response to radiation therapy following radical prostatectomy, say the developers.
read article (free registration required) 



Common Genetic Disorder Linked to Increased Death Rate From Cancer Drug

(Fred Hutch News Service) Oct 27, 2016 - Research published Thursday shows that a common genetic disorder — one that many people don’t even know they have — is linked to a more than twofold increase in death rates among patients treated with a particular cancer drug.
read article 



Be Your Own Control: Cancer Sequencing Differs Based on Genetic Background of Reference Genome

(UCCC/Colorado Cancer Blogs) Oct 27, 2016 - When University of Colorado Cancer Center researcher, Jing Hong Wang, MD, PhD, found more than 1,000 genetic translocations in her mouse model of B cell lymphoma, she assumed her lab had made a mistake.
read article 



Antibody Breaks Leukemia’s Hold, Providing New Therapeutic Approach

(UC San Diego Health) Oct 27, 2016 - Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers at University of California San Diego School of Medicine and Moores Cancer Center discovered that a cell surface molecule known as CD98 promotes AML.
read press release 



Promise of Better Targeted Treatments Now Possible in Children’s Brain Cancer

(Huntsman Cancer Institute University of Utah) Oct 27, 2016 - More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer.
read press release